Punathil and Katiyar [28] have examined the effect of GSPs on non-small cell lung cancer cell migration, and found that GSPs inhibit the migration of these cells by targeting nitric oxide, guanylate cyclase and ERK1/2 pathways. Here, MAPK3 is linked to non-small cell lung carcinoma.